{
    "Variants Include": [
        {
            "Gene": "SNCA",
            "variants": [
                {
                    "HGVS": "NM_001146112.3:c.158G>A",
                    "cDNA Change": {
                        "transcript": "NM_001146112.3",
                        "ref": "G",
                        "alt": "A",
                        "position": "158"
                    },
                    "Protein Change": {
                        "ref": "A",
                        "alt": "T",
                        "position": "53"
                    },
                    "Description in input context": "A53T a-synuclein mutation"
                }
            ]
        }
    ],
    "Described Disease": {
        "Described Disease": "Familial Parkinson’s disease",
        "MONDO": "MONDO:0005586"
    },
    "Experiment Method": [
        {
            "Assay Method": "Immunohistochemical analysis",
            "Material used": {
                "Material Source": "Postmortem tissue",
                "Material Name": "Brain tissue from patient IX-51 of the Contursi kindred",
                "Description": "The patient studied here is a member (IX-51) of the Contursi kindred that has been followed clinically since the mid-1980s."
            },
            "Readout type": "Qualitative",
            "Readout description": [
                {
                    "Variant": "NM_001146112.3:c.158G>A",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "Fibrillization of a-synuclein and tau",
                    "Result Description": "Insoluble filamentous a-syn lesions were detected in almost all brain regions examined and significant accumulations of filamentous insoluble tau protein also were detected in some brain regions of this patient."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "N.D.",
                "Description": "N.D."
            },
            "Technical replicates": {
                "Technical replicates": "N.D.",
                "Description": "N.D."
            },
            "Basic positive control": {
                "Basic positive control": "N.D.",
                "Description": "N.D."
            },
            "Basic negative control": {
                "Basic negative control": "N.D.",
                "Description": "N.D."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "N.D.",
                "Counts": "N.D."
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "N.D.",
                "Counts": "N.D."
            },
            "Statistical analysis method": {
                "Statistical analysis method": "N.D."
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "N.D.",
                "Source": "N.D."
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "N.D.",
                "Source": "N.D."
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        },
        {
            "Assay Method": "Biochemical analysis",
            "Material used": {
                "Material Source": "Postmortem tissue",
                "Material Name": "Brain tissue from patient IX-51 of the Contursi kindred",
                "Description": "One-gram samples of frozen brain tissue from cingulate cortex, midfrontal cortex, cerebellum and hippocampus, and 0.15 g samples of 10 different subcortical areas were fractionated based on their differential extractability using buffered solutions of increasing solubilization strengths."
            },
            "Readout type": "Qualitative",
            "Readout description": [
                {
                    "Variant": "NM_001146112.3:c.158G>A",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "Accumulation of insoluble a-syn and tau",
                    "Result Description": "Significant levels of insoluble tau were detected in several brain regions and the highest levels were recovered from dorsal pons."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "N.D.",
                "Description": "N.D."
            },
            "Technical replicates": {
                "Technical replicates": "N.D.",
                "Description": "N.D."
            },
            "Basic positive control": {
                "Basic positive control": "N.D.",
                "Description": "N.D."
            },
            "Basic negative control": {
                "Basic negative control": "N.D.",
                "Description": "N.D."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "N.D.",
                "Counts": "N.D."
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "N.D.",
                "Counts": "N.D."
            },
            "Statistical analysis method": {
                "Statistical analysis method": "N.D."
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "N.D.",
                "Source": "N.D."
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "N.D.",
                "Source": "N.D."
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        },
        {
            "Assay Method": "In vitro fibril formation assays",
            "Material used": {
                "Material Source": "Bacterial recombinant proteins",
                "Material Name": "Tau T40 and wild-type (WT) and A53T mutant a-synuclein",
                "Description": "Polymerization of bacterial recombinant tau T40 with recombinant wild-type (WT) and A53T mutant a-synuclein was monitored after 24-, 48-, and 96-h incubations with constant agitation at 37°C."
            },
            "Readout type": "Quantitative",
            "Readout description": [
                {
                    "Variant": "NM_001146112.3:c.158G>A",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "Accelerated fibril formation",
                    "Result Description": "The A53T mutation accelerated a-synuclein fibril formation, initiated tau assembly into filaments, and synergistically enhanced fibrillization of both tau and a-synuclein."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "Yes",
                "Description": "n = 4 samples"
            },
            "Technical replicates": {
                "Technical replicates": "N.D.",
                "Description": "N.D."
            },
            "Basic positive control": {
                "Basic positive control": "N.D.",
                "Description": "N.D."
            },
            "Basic negative control": {
                "Basic negative control": "N.D.",
                "Description": "N.D."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "N.D.",
                "Counts": "N.D."
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "N.D.",
                "Counts": "N.D."
            },
            "Statistical analysis method": {
                "Statistical analysis method": "N.D."
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "N.D.",
                "Source": "N.D."
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "N.D.",
                "Source": "N.D."
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        }
    ]
}